Biogen Inc.
$BIIB
Public valuation for Biogen Inc. (BIIB). Fair value, signal, and key metrics — no sign-in required.
Current Price
$225.88
34% Overvalued
Fair Value Estimate
$148
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $238.18
5% higher than current
Key Metrics
Market Cap
$33.4B
Forward P/E
21.0x
Operating Margin
5.5%
Revenue Growth
-0.5%
PEG Ratio
7.83
Get free watchlist alerts
Join the waitlist for valuation updates on $BIIB and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.